Canopy Growth Corporation (CGC) vs Tilray Brands, Inc. (TLRY)

Canopy Growth Corporation and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Tilray Brands, Inc. is the larger, with a market value of $474.4M against $311.2M — 1.5× the size. Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against 7.80%. Tilray Brands, Inc. has the higher net margin (−17.1% vs −80.4%) and the higher return on invested capital (−3.21% vs −17.2%). Across the 18 metrics below, Tilray Brands, Inc. leads on 15 and Canopy Growth Corporation on 3.

Valuation

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 1.41 0.42 2.11
P/B 0.60 0.25 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 1.07 0.56 2.73
Earnings yield (62.58%) (45.40%) (4.38%)
Free cash flow yield (20.24%) (43.04%) 0.00%

Profitability

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Gross margin 25.16% 29.12% 53.94%
Operating margin (54.89%) (9.26%) 0.00%
Net margin (80.39%) (17.05%) 0.00%
Free cash flow margin (28.34%) (18.11%) 0.00%
Return on equity (40.14%) (10.50%) (0.40%)
Return on assets (23.54%) (7.45%) (3.32%)
Return on invested capital (17.19%) (3.21%) 0.00%

Growth

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 7.80% 15.93% 10.01%
EPS growth (last fiscal year) 84.00% 95.57% 49.06%
Revenue growth, 5-year CAGR (13.04%) 7.82% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Debt to equity 0.35 0.22 0.05
Current ratio 3.04 1.88 2.31
Net debt to EBITDA 1.09 11.34 0.97

Dividend

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric CGC TLRY Drug Manufacturers Specialty & Generic median
Market cap 311.15m 474.40m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack